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Nitric oxide (NO) is an important mediator of cardiovascu-lar homeostasis through its ability to exert physiological 
effects on numerous cells types of the vasculature. NO coor-
dinates several biological functions, including blood flow, 
proportional vascular remodeling, and angiogenesis. In the 
endothelium, NO is primarily generated through eNOS (endo-
thelial nitric oxide synthase) in response to local agonists (ie, 
bradykinin, acetylcholine) and alterations in hemodynamics. 
NO can subsequently diffuse through the plasma membrane 
to the underlying vascular smooth muscle layer to regulate 
cGMP-dependent vascular relaxation and systemic blood 
pressure. Enzyme activity is also essential for NO diffusion 
into the lumen, where binding to hemoglobin in erythrocytes 
provides circulating NO bioequivalents.
The in vivo regulation of eNOS is a complex process that 
involves multiple interdependent control mechanisms such 
as lipidation, subcellular localization, intracellular calcium, 
substrate availability, and phosphorylation at key activation 
sites, namely serine 1177 (in human eNOS; mouse: S1176; 
bovine: S1179).1,2 Phosphorylation of eNOS at S1177 has 
previously been shown to occur at low levels of intracellu-
lar calcium (ie, with shear stress, insulin),3,4 highlighting the 
various avenues of eNOS activation. Although several kinases 
have been identified for eNOS-S1177 phosphorylation (ie, 
PKA, AMPK),5 S1177 phosphorylation occurs in vivo pre-
dominantly through Akt.6 The protein kinase Akt is a major 
hub for several signal transduction pathways through its abil-
ity to phosphorylate numerous downstream targets directly 
involved in various cellular processes including prolifera-
tion, cell survival, and metabolism—all critical for vascu-
lar remodeling.7,8 Akt has also been shown to preferentially 
phosphorylate the eNOS isoform over other NOS isoforms, 
as cotransfection of Akt with nNOS and iNOS does not 
induce NO release.4 Biochemical approaches validate S1176 
phosphorylation as the main activation site in intact cells, as a 
loss-of-function mutation to alanine (S1176A) abolishes Akt-
dependent eNOS phosphorylation and reduces NO release. 
Similarly, a gain-of-function mutation to mimic phosphoryla-
tion (S1176D) results in significantly enhanced in vitro eNOS 
enzyme activity.3,4 We have additionally shown the functional 
importance of S1176 phosphorylation in vasomotor tone reg-
ulation, as S1179D adenoviral delivery restores endothelial 
cell (EC)–dependent vasodilatory responses in pressurized 
arteries from eNOS knockout mice.9 Furthermore, genetic 
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Approach and Results—Herein, we used an inducible, endothelial-specific Akt1-deleted adult mouse model (Akt1iECKO) 
to characterize the endothelial cell autonomous functions of Akt1 in the vascular system. Endothelial-targeted ablation of 
Akt1 reduces eNOS (endothelial nitric oxide synthase) phosphorylation and promotes both increased vascular contractility 
in isolated vessels and elevated diastolic blood pressures throughout the diurnal cycle in vivo. Furthermore, Akt1iECKO 
mice subject to the hindlimb ischemia model display impaired blood flow and decreased arteriogenesis.
Conclusions—Endothelial Akt1 signaling is necessary for ischemic resolution post-injury and likely reflects the consequence 
of NO insufficiency critical for vascular repair.
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knockin approaches indicate that Akt1 is the primary kinase 
for eNOS in vivo, as introduction of the S1176D phospho-
mimic mutation in global Akt1 knockout mice rescues the 
profound defects in revascularization after hindlimb ischemia 
(HLI) and wounding these mice.6
Of the 3 Akt isoforms (Akt1/Akt2/Akt3), ECs express pre-
dominantly Akt1, the major isoform involved in the regula-
tion of cardiovascular function.10–13 We have previously shown 
the isoform-dependent role of Akt in vascular remodeling, 
as ischemic limb repair is severely impaired in global Akt1 
knockout mice.10 Unlike the pronounced defects seen in Akt1 
knockout mice on injury, global Akt2 knockout mice display 
normal hindlimb flow recovery, paralleling the in vitro obser-
vation of preferential eNOS-S1177 phosphorylation through 
the Akt1 isoform when compared with the Akt2 isoform.10,11 
On a whole organism level, however, global loss of Akt1 
results in severe growth defects both in utero and postnatal 
life, as Akt1KO mice remain smaller than average throughout 
adulthood.14,15 The obvious growth retardation together with 
the increased propensity to apoptosis in global Akt1 knockout 
mice thus limits the interpretation of how the Akt1 isoform 
regulates adult vascular remodeling. Furthermore, the protein 
kinase Akt1 is positioned as a key signaling intermediate in all 
cell types, thereby confounding theoretical predictions as to 
the tissue-specific role of Akt1.
Here, we use an inducible, endothelial-specific Akt1-null 
adult mouse model (Akt1iECKO) to address the EC-specific, 
postnatal role of Akt1 in vivo. Akt1iECKO mice display phe-
notypes indicative of impaired eNOS function and consequent 
endothelial dysfunction. We show that endothelial Akt1 abla-
tion promotes a spontaneous hypertensive phenotype associ-
ated with EC dysfunction. Furthermore, Akt1iECKO mice 
subject to HLI display diminished blood flow recovery where 
micro-CT imaging indicates an associated impairment of arte-
riogenesis. Collectively, the cardiovascular phenotypes that 
arise because of the postnatal deletion of Akt1 in EC support 
the critical role of the Akt–eNOS signaling axis in the regula-




The Akt1flox/flox16 were bred to the Cdh5-Cre-ERT217 mice to obtain 
inducible, endothelial-targeted Akt1 mice, as previously described.11 
Young adult, male mice (≈4–5 weeks of age) were injected with 
tamoxifen (100 μg/g total body weight) via intraperitoneal delivery 
for 7 consecutive days. Phenotyping assessments were performed 6 
weeks post-tamoxifen administration (≈10–12 weeks of age).
En Face Immunostaining
Thoracic aortas were isolated from control and Akt1iECKO imme-
diately after euthanize. Aortas (or indicated arteries) were isolated 
and cut longitudinally for en face immunostaining. The isolated tis-
sues were incubated at 37°C in serum-free base media for ≈4 hours 
before ex vivo treatment with Ang1 (angiopoietin-1; 500 ng/mL) or 
PDGF (platelet-derived growth factor)-BB (50 ng/mL) for the indi-
cated times. Samples were then fixed in 4% PFA/PBS and permeabi-
lized overnight in TNB blocking buffer (0.1 mol/L Tris pH 7.4, 150 
mmol/L NaCl, 0.2% Triton-X-100, 0.5% blocking reagent) for whole-
mount analysis. Aortas were stained with rat anti-VECD (BD555289, 
1:200), mouse anti-GM130 (BD610822, 1:100), rabbit anti-panAkt 
(Cell Sig No. 9272, 1:200), and rabbit anti-p-eNOS-S1176 (Cell Sig 
No. 9571, 1:200). Images were acquired using a Leica SP5 confocal 
microscope with the Leica Application Suite software. Images reflect 
a z-stack compression of the endothelial layer using the sequential 
scan mode with an HCX PL APO λ blue 63×/1.40 oil objective.
NO Bioavailability (Electric 
Paramagnetic Resonance)
Electric paramagnetic resonance was applied to measure hemoglobin-
bound NO (Hb-NO) in whole blood, as previously described.18 In brief, 
mice were euthanized by CO
2
 inhalation for subsequent blood isolation 
from the inferior vena cava. Samples were immediately flash-frozen 
in liquid N
2
 for later spectrometer analysis. Mice harboring germline 
eNOS knockin mutations (S1176D+/+ and S1176A+/+)6 and lacking 
eNOS19 were used as gating controls for Hb-NO signal detection. All 
mice were given standard chow to ensure fixed levels of nitrate/nitrite 
content to prevent dietary influences on NO bioavailability.
Wire Myography
Wire myography was performed, as previously described.20 Thoracic 
aortas were isolated and cleaned under a dissecting scope to remove 
residual fat and connective tissues. Aortic rings of uniform length 
were suspended using 2 tungsten wires through the lumen and sub-





, 37°C). Aortic rings were set to a resting 
tension of 1.5 g under isometric conditions and allowed to equilibrate. 
After equilibration, aortic rings were subject to several rounds of KCl 
contraction followed by contractile-induced dose–response curves. 
For relaxation studies, aortic rings were pre-constricted to ≈80% 
maximal constriction before acetylcholine dose-curve generation. 
Increasing concentrations of the desired agents were administered at 
half-log increments where real-time responses were recorded using 
Chart5 (AD Instruments). Control and Akti1ECKO aortic rings were 
studied simultaneously, isolating at least 3 to 4 aortic rings per mouse. 
Tension–response curve data reflect a nonlinear regression curve (log 
[agonist] versus response) using Prism 6.0 (GraphPad Software).
Blood Pressure Telemetry
Radiotelemetric blood pressure catheters were implanted in the right 
carotid artery of adult male (10–12 weeks old) mice and allowed to 
recover 1 week from surgery, as previously described.21,22 Mice were 
housed in individually controlled environments with a 12-hour light/
dark cycle with free access to food and water. Parameters of inter-
est were measured at 1-minute intervals for 7 consecutive days. Data 
reflect averaged values over a 3-day reading period.
Hindlimb Ischemia
The HLI model was performed, as previously described.23,24 In brief, 
the left femoral artery and the proximal portion of the saphenous 
artery are exposed, ligated, and excised. Ischemic and nonischemic 
limb perfusion is measured pre-, post-surgery, 1-, 2-, 3-, and 4-weeks 
after surgery using Laser Doppler scanning (LDI; Moor Instruments 
Ltd). Perfusion data are analyzed and reported as a ratio of flow in 
the injured relative/contralateral leg values. S-Nitroso-N-acetyl-DL 
Nonstandard Abbreviations and Acronyms
Ang1 angiopoietin-1
EC endothelial cell
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penicillamine was injected locally (1 mg/mL, 30 μL injection) where 
indicated before Laser Doppler scanning and flow measurements.
Micro-CT Imaging
Two-dimensional micro-CT scans were obtained using a GE eXplore 
MS Micro-CT System, as previously described.23 Mice were adminis-
tered 2% adenosine before delivery of the contrast agent to dilate the 
vascular bed and definitively assess the effects on anatomy and vascu-
lar remodeling rather than vascular tone. Vessel density analyses were 
performed on captured images, as previously described.23
Statistical Analysis
All data are shown as mean±SEM. Statistical significance was deter-
mined based on a P value calculation of P<0.05, where all compari-
sons reflect a 2-way ANOVA, Bonferroni analyses.
Results
Inducible Deletion of Adult 
Endothelial Akt1 Expression
Although viable, global Akt1-null mice exhibit significant neo-
natal mortality and are substantially smaller than WT littermate 
controls.14,15 Therefore, we used an inducible, tissue-specific 
approach to bypass potential retardation effects during gesta-
tion/growth as a result of global Akt1 loss. Inducible, endothe-
lial-targeted (Cdh5-Cre-ERT2) Akt1 mice were generated using 
Cre-loxP technology, as described previously.11 Young adult 
mice (≈4–5 weeks of age) were administered tamoxifen for 7 
consecutive days via intraperitoneal injection for adult pheno-
typing at ≈10 to 12 weeks of age (Figure IA in the online-only 
Data Supplement). Whereas global Akt1 deletion yields sig-
nificantly smaller mice, inducible deletion does not affect total 
body weight (Figure IB in the online-only Data Supplement), 
thereby eliminating body mass as a variable. En face whole-
mount immunofluorescent imaging of the endothelial layer 
from various arterial vessels indicates near-complete ablation of 
total Akt1 protein expression (Figure II in the online-only Data 
Supplement), thus validating the inducible deletion strategy. The 
Akt antibody was determined to be specific, as immunofluores-
cent labeling is undetectable in the endothelium of global Akt1 
knockout mice (Figure III in the online-only Data Supplement).
Endothelial Akt1 Deletion Attenuates Ang1- and 
PDGF-Stimulated eNOS Phosphorylation
Akt1 is the major isoform in the endothelium necessary for 
mediating proangiogenic signaling events13 and has been dem-
onstrated by several groups as a major kinase for eNOS phos-
phorylation and subsequent eNOS activation.3,4,10,25 Therefore, 
we sought to assess eNOS function using an ex vivo approach to 
validate the endothelial-targeted Akt1 knockout mouse model.11 
In brief, segments of the thoracic aorta were isolated from adult 
Akt1iECKO mice along with respective littermate controls and 
incubated with Ang1, a prototypical PI3K/Akt agonist to induce 
eNOS phosphorylation on S1176.26–29 The phospho-eNOS 
antibody was determined to be specific for S1176, as immu-
nofluorescence labeling detected phospho-eNOS-S1176 signal 
in control vessels but not in vessels isolated from mice har-
boring a loss-of-function mutation in the Akt phosphorylation 
site (eNOS-S1176A mice6; Figure IV in the online-only Data 
Supplement). As seen in Figure 1A and 1B, en face staining 
for phospho-eNOS-S1176 demonstrates enhanced perinuclear 
phospho-eNOS levels30 in response to acute Ang1 treatment, 
where this effect is significantly reduced in Akt1iECKO mice. 
We similarly stimulated vessels with PDGF-BB, a potent growth 
factor that activates Akt in the endothelium and induces endo-
thelium-dependent relaxation in intact vessels.31,32 PDGF-BB 
treatment of control aortas induces eNOS phosphorylation, thus 
corroborating previous observations where PDGF-BB treatment 
produced NO-mediated vessel relaxation,32 as endothelial-spe-
cific Akt1 deletion reduces eNOS-S1176 phosphorylation levels 
(Figure VA in the online-only Data Supplement and quantified 
in Figure VB in the online-only Data Supplement).
Endothelial Loss of Akt1 Decreases 
NO Bioavailability
The transfer of eNOS-derived NO to hemoglobin in circulat-
ing erythrocytes relies on the diffusional distance and serves as 
a critical determinant of plasma NO bioavailability.33 Thus, the 
formation of Hb-NO is directly proportional to the amount of 
bioavailable NO.34 Because of the stable nature of Hb-NO under 
anaerobic conditions, Hb-NO levels measured by electron para-
magnetic spin resonance techniques in isolated mouse blood35 
reflect eNOS-derived NO levels in blood. Therefore, we mea-
sured Hb-NO levels in Akt1iECKO adult mice to determine 
whether the loss of endothelial Akt1 affected NO bioavailability 
(Figure 1C). Venous whole blood was collected from adult mice, 
and Hb-NO was measured using electron paramagnetic spin res-
onance, as previously described.18 Genetically modified eNOS 
mutant mice either mimicking (S1176D) or lacking (S1176A) 
eNOS phosphorylation6 were additionally assessed together with 
eNOS knockout as thresholding controls to determine the win-
dow of detection. All mice were given standard chow and food 
restricted overnight to ensure fixed levels of nitrate/nitrite con-
tent to prevent dietary influences on NO bioavailability measure-
ments. Although higher than the loss-of-function eNOS-S1176A 
mutant, Akt1iECKO mice show significantly less Hb-NO in 
blood compared with WT littermate controls, highlighting the 
importance of the Akt1–eNOS axis in regulating NO bioactivity.
Endothelial Loss of Akt1 Decreases Basal NO 
Levels and Impairs Vascular Function
Ex vivo examination of adult Akt1iECKO aortas clearly dem-
onstrates blunted levels of eNOS phosphorylation. To test the 
significance of these findings in intact vessels, myography 
was used to examine vascular function in aortic rings from 
Akt1iECKO mice. Aortic rings isolated from both control 
and Akt1iECKO adult mice were subjected to various ago-
nists, and tension–response curves were generated. Typical 
contraction and relaxation responses were observed in con-
trol mice, with an EC50 for phenylephrine and acetylcholine 
matching previously reported values36 (Figure 2A and 2B). 
However, aortic rings from Akt1iECKO mice had increased 
sensitivity to the contractile actions of phenylephrine and 
KCl (Figure 2A and 2C), where pre-incubation of vessels 
with the NOS inhibitor, l-NAME, normalized the phenyleph-
rine response in Akt1iECKO mice (Figure 2D). This response 
suggests that tension-induced release of NO, or basal NO 
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Acetylcholine-dependent vessel relaxation in conduit vessels 
occurs primarily through the release of endothelial-derived 
NO.37 Interestingly, acetylcholine-mediated reductions in vas-
cular tone were virtually indistinguishable between the groups 
(Figure 2B), demonstrating that endothelial Akt1 is not criti-
cal for acetylcholine-mediated NO production, which occurs 
primarily through Ca2+/CaM-dependent mechanisms.2,38
Endothelial-Specific Loss of Akt1 Significantly 
Increases Diastolic Blood Pressure
Arterial pressure is of particular importance in maintain-
ing vascular function and response, relying heavily on 
shear stress–mediated endothelial NO production.39 The 
observed decrease in eNOS phosphorylation and circulat-
ing Hb-NO together with the increased sensitivity to phen-
ylephrine suggests that overall systemic blood pressure 
may be affected in Akt1iECKO mice. Therefore, arterial 
blood pressure and heart rate were monitored in intact, 
conscious mice for over 72 hours using implanted telem-
etry devices.40 Akt1iECKO mice display elevated diastolic 
pressures independent of the time of day (Figure 3A and 
3B) and an associated inclination toward increased mean 
arterial pressures (Figure VIA in the online-only Data 
Supplement). Previous studies using similar telemetry-
based blood pressure measurements in global Akt1KO mice 
report nonsignificant trends toward increased arterial pres-
sure,41 thus denoting the Akt1iECKO phenotype as the first 
report of hypertension resulting from Akt1 impairment. 
Other parameters, such as systolic blood pressure, heart 
rate, and activity levels, were comparable between control 
and adult Akt1iECKO mice (Figure 3C and 3D; Figure VIB 
in the online-only Data Supplement).
A
B C
Figure 1. Endothelial loss of Akt1 impairs stimuli-induced eNOS (endothelial nitric oxide synthase) phosphorylation and decreases NO 
bioavailability. A, Isolated thoracic aorta segments from Akt1iECKO mice display decreased phospho-eNOS S1176 when treated with 
Ang1 (angiopoietin-1) ex vivo, quantified in (B). C, Less hemoglobin-bound NO (NO-Hb) levels were detected in peripheral blood of 
Akt1iECKO adult mice when assessed by electron paramagnetic spin resonance (EPR) techniques. eNOS mutant (S1176D and S1176A) 
and global eNOS knockout (KO) mice were used as gating controls for NO-Hb levels. The number of mice for each genotype shown as 
indicated. All data are mean+SEM, n=3 to 6 mice per group, 2 to 6 images per mouse. *P<0.05, **P<0.01. AU indicates arbitrary units; 
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Endothelial Loss of Akt1 Results in 
Impaired Blood Flow Recovery and 
Decreased Arteriogenesis on HLI
In a model of HLI, the global loss of PI3Kγ42 or Akt110 
results in critical limb ischemia and limb loss concomitant 
with marked impairment in arteriogenesis and angiogenesis. 
Nevertheless, the observed defects in global Akt1-deficient 
mice likely reflect a complex response, involving multiple 
cells types (eg, EC, SMC, macrophages), all of which express 
the Akt1 isoform. We first assessed baseline arterial density 
in the EC-inducible Akt1 deletion model using a phase con-
trast agent together with micro-CT imaging. Arterial vessels 
were maximally dilated to definitively assess the vascular 
network rather than vascular tone, where quantification did 
not indicate any underlying deficits in artery number before 
hindlimb injury between both groups (data not shown). We 
subsequently performed the HLI model in Akt1iECKO and lit-
termate controls to assess the role of EC-specific Akt1 expres-
sion in this injury response. In brief, the left femoral artery 
was ligated and removed, on which blood flow is measured 
over time using Laser Doppler imaging. Perfusion rates in the 
surgically manipulated leg were normalized to the uninjured 
contralateral limb for blood flow quantification. In control 
mice, an acute decrease in blood flow was followed by pro-
gressive recovery of flow over 28 days post-injury. In contrast, 
flow recovery in Akt1iECKO was significantly impaired by 14 
days and persisted to 28 days post-ischemia when compared 
with littermate controls (Figure 4A and 4B). To assess arterial 
density after injury, micro-CT imaging was conducted 14 days 
post-HLI.43 Micro-CT analyses indicate a significant decline 
in the number of smaller arteries both above and below the 
knee in Akt1iECKO mice post-ischemia (Figure 4C through 
4E), suggesting that collateral remodeling and the develop-
ment of new arterial branches was impaired by the loss of the 
Akt1 isoform in ECs.
To reinforce the importance of Akt1-mediated eNOS 
activation for vascular recovery, a rescue experiment was 
performed using S-Nitroso-N-acetyl-DL-penicillamine,44 as 
an NO donor. Global Akt1 knockout mice were used for res-
cue experiments because the deficit in blood flow after HLI 
is much larger compared with reduced flow recovery in the 





Figure 2. Basal NO production in vessels requires endothelial Akt1. A, Aortic rings from Akt1iECKO display increased sensitivity to phen-
ylephrine (PE)-induced constriction, whereas (B) acetylcholine (Ach)-induced vascular relaxation is maintained, suggesting basal impaired 
NO production in Akt1iECKO mice. Aortic rings from Akt1iECKO mice display enhanced (C) KCl-induced (60 mmol/L) constriction, where 
(D) pre-incubation of vessels with l-NAME normalizes the differences in PE sensitivity. Data are mean±SEM, n=4 to 9 mice per group, 3 to 
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Data Supplement, administration of S-Nitroso-N-acetyl-DL 
penicillamine with a single-injection downstream of the injury 
site resulted in near immediate flow recovery in the injured 
limb of control mice, with even greater flow increases in 
global Akt1 knockout mice. The timely increase in blood flow 
suggests the presence of a remodeled, yet dysfunctional and 
constricted vasculature in global Akt1 knockout mice, where 
eNOS activation may be critical for injury resolution through 
both neovessel formation and vasomotor tone regulation.
Discussion
Akt1 controls many signaling pathways that regulate cell 
survival, morphogenesis, and growth.7 Although global Akt1-
null mice have been instrumental in elucidating the in vivo 
biological role of Akt1, the contribution of Akt1 signaling 
from a cell-specific perspective has only recently begun to be 
explored.11,16,45–47 Here, we show that endothelial loss of Akt1 
using an inducible, postnatal EC-specific strategy results in 
spontaneous hypertension, decreased NO bioavailability, and 
impaired recovery to tissue limb ischemia—all indicative of 
impaired NO production. These data are surprising given that 
eNOS can be phosphorylated on S1176 in vitro by several 
kinases including other AGC kinases (protein kinase A, G, 
C) and AMPK.48 The Akt1iECKO phenotypes indicative of 
impaired NO production suggest that physiologically, eNOS-
S1176 phosphorylation in vivo through Akt1 is crucial for NO 
tone and blood pressure control.
A common feature of endothelial dysfunction is dimin-
ished NO bioavailability, where eNOS knockout mice are an 
extreme state of NO deficiency.1 Regardless of the method-
ology used for blood pressure measurements, eNOS knock-
out mice are consistently hypertensive19,49–52 and display an 
associated increase in cardiac mass and function.52 Akt1 has 
been well established as a major kinase for eNOS phosphor-
ylation3,4,6 and manipulation of Akt activity in vivo through 
use of viral transfection methods in combination with arterial 
flow measurements indicate that short-term hyperactivation of 
Akt1 results in augmented NO release, enlarged vessel diame-
ter, and enhanced blood flow.53 In addition, EC-specific trans-
genic expression of Akt1 increases NO production and reduces 
injury-induced neointima formation.54 Although global Akt1 
knockout mice present phenotypes similar to eNOS knock-
out, such as decreased homozygote offspring number and 





Figure 3. Adult, endothelial-specific loss of Akt1 significantly increases diastolic BP. A, Telemetry readings indicate an elevated diastolic 
pressure in free-roaming, conscious Akt1iECKO mice. The increase occurred during the diurnal cycle (B). The loss of Akt had no effect 
on systolic pressure, (C) or heart rate (D), Data are mean±SEM with n=6 mice per group. **P<0.01, ***P<0.001. Graphs illustrate a 3-day 
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not hypertensive.11,41 Normal blood pressures in global Akt1 
knockout mice suggest that other kinases may regulate eNOS 
or that the global loss of Akt1 promotes compensation by other 
expressed Akt isoforms given the significant overlap in sub-
strate specificity for Akt1 versus Akt2 in the endothelium.11 
Thus, the hypertensive phenotype in adult Akt1iECKO mice 
emphasizes the importance of the endothelial Akt1–eNOS 
axis in vivo6 and suggests that adaptive changes likely occur 
during development that preclude an obvious blood pressure 
phenotype in global Akt1 knockout mice.
Moreover, cardiac output rates derived from echo-
cardiography measurements did not indicate any differ-
ences between Akt1iECKO and littermate controls (data 
not shown). Given the direct relationship between blood 
pressure and peripheral resistance, the observed pressure 
elevation together with the lack of change in cardiac output 
suggests that the Akt1iECKO mice likely exhibit increased 
systemic vascular resistance. Although smaller resistance 
arteries have been conventionally reliant on endothelium-
derived hyperpolarizing factor as the predominant media-
tor of vascular tone regulation, the recent discovery of 
Hbα (hemoglobin α) in the myoendothelial junctions of 
resistance arteries suggests a role for NO scavenging.55 
The localized nature of Hbα at the myoendothelial junc-
tion may serve as a chelator of eNOS-derived NO to favor 
endothelium-derived hyperpolarizing factor activity while 
maintaining control over NO levels. Previous groups have 
also shown the importance of eNOS expression on periph-
eral vascular tone, as partial deletion of eNOS increases 





Figure 4. Endothelial loss of Akt1 results in impaired blood flow recovery on femoral artery ligation and reduced arteriogenesis. A, Endo-
thelial-specific loss of Akt1 results in impaired blood flow recovery in response to hindlimb ischemia (HLI) 14 days post-ischemia. Rela-
tive blood flow perfusion ratio shown in (B). C, Arterial phase micro-CT analyses at 14 days post-injury indicates significant reduction in 
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complementing the impaired vascular tone seen in isolated 
vessels from Akt1iECKO mice (Figure 2).
Vascular remodeling occurs in both development and 
under adult pathological conditions, requiring various adapta-
tions in response to the physiological environment and patho-
logical stimuli. Angiogenesis denotes the de novo formation 
of capillaries from preexisting postcapillary venules and is 
largely initiated by hypoxic events, whereas arteriogenesis 
denotes the remodeling of preexisting collaterals or arteri-
oles/capillaries, which is generally ischemia independent 
and driven through hemodynamic and inflammatory factors 
(ie, shear stress, wall tension).58,59 In experimental models of 
HLI, arteriogenesis is stimulated through a marked increase 
in fluid shear stress in arterial conduit vessels, providing a 
driving force to promote collateralization.60 In the distal lower 
limb, vascular remodeling is primarily mediated through tis-
sue ischemia, resulting in the upregulation of several growth 
factors critical for vascularization. eNOS-derived NO serves 
as a naturally occurring, compensatory mechanism to regu-
late hemodynamic changes in both normal and ischemic tis-
sues.61 eNOS function is also essential for native collateral 
formation, immediate flow recovery post-ligation, and cellu-
lar recruitment in the remodeling vasculature—all of which 
are critical for efficient arteriogenesis.62,63 The defective flow 
recovery in adult Akt1iECKO mice herein likely reflects the 
combinatorial effects of impaired eNOS-derived NO genera-
tion given the established role of the Akt1 kinase in eNOS-
S1179 phosphorylation.6 However, the impairment in blood 
flow and arteriogenesis in Akt1iECKO mice is markedly 
less than that observed in global Akt1 knockout10 or eNOS 
knockout mice,64 implying that other kinases may contribute 
to eNOS activation under these conditions or that expression 
of Akt1 is also critical in SMCs and macrophages for proper 
ischemic injury repair.
Recent work using conditional EC-specific Akt1 dele-
tion mice has shown that the Akt1 isoform is necessary for 
developmental retinal angiogenesis through regulation of EC 
proliferation and survival,11 2 well-described functions of Akt 
and downstream substrate phosphorylation. Furthermore, 
the global deletion of Akt2 in combination with EC-specific 
deletion of Akt1 did not further impair the developing reti-
nal vasculature. In contrast, deletion of endothelial Akt1 in 
adult mice had a mild effect on cardiac arteriogenesis (quanti-
fied via micro-CT), and this effect was markedly exacerbated 
by the global deletion of Akt2,45 implying functional redun-
dancy of these isoforms in the adult coronary vasculature. 
Mechanistically, the loss of both isoforms in EC, and Akt2 in 
smooth muscle, reduce endothelial expression of the Notch 
ligand, Jagged1, thereby impairing Notch-Jagged regulation 
of vascular stability. The means by which Akt as a kinase 
regulates this pathway are not clear, as an Akt substrate has 
not yet been identified to explain the reduced Jagged1 lev-
els. Prior work has shown that Akt2 exerts a more prominent 
role in determining vascular SMC phenotype and function.65,66 
Global Akt2 knockout mice are additionally more susceptible 
to aortic aneurysms,67 further demonstrating a role for the 
Akt2 isoform in vascular tone regulation and vessel compli-
ance through an NO-independent pathway. Nevertheless, our 
studies indicate that in vivo eNOS activity is mediated primar-
ily through the endothelial expression of Akt1 where postna-
tal deletion results in defects consistent with decreased NO 
bioavailability.
Collectively, our data support the importance of the 
Akt1–eNOS signaling axis in intact endothelium given its 
primary role in NO production and vasomotor tone regula-
tion. Akt1iECKO mice display phenotypes indicative of 
NO insufficiency as seen through impaired agonist-induced 
eNOS phosphorylation, blunted endothelial NO production 
in vivo, diastolic hypertension, and defects in postischemic 
arteriogenesis. Hence, PI3K-Akt1-NO signaling in EC is 
critical for vascular tone regulation and adaptive vessel 
remodeling.
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Highlights
• Endothelial-specific Akt1 ablation in adult mice results in spontaneous hypertension.
• Adult, inducible, endothelial-targeted Akt1 deletion results in decreased NO bioavailability.
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